BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2996003)

  • 1. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
    Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
    Corell B; Zoll B
    FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EcoRI restriction fragment length polymorphism (RFLP) in the human c-erb A locus.
    Mathieu-Mahul D; Xu DQ; Saule S; Lidereau R; Galibert F; Berger R; Mauchauffé M; Larsen CJ
    Hum Genet; 1985; 71(1):41-4. PubMed ID: 2993156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the c-mos locus in "normal" tissues from humans exposed to radium.
    Hardwick JP; Schlenker RA; Huberman E
    Cancer Res; 1989 May; 49(10):2668-73. PubMed ID: 2565761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pst I restriction fragment length polymorphism of the human placental alkaline phosphatase gene in normal placentae and tumors.
    Tsavaler L; Penhallow RC; Kam W; Sussman HH
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4529-32. PubMed ID: 2885837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the estrogen receptor gene structure in human breast cancer.
    Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
    Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
    Chenevix-Trench G; Southall M; Kidson C
    Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients.
    Hollstein M; Montesano R; Yamasaki H
    Nucleic Acids Res; 1986 Nov; 14(21):8695. PubMed ID: 2878411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restriction fragment length polymorphism of c-fos and c-src oncogene loci in spontaneously hypertensive (SHR) and control (WKY) rats].
    Kotelevtsev IuV; Brashishkite DA; Spitkovskiĭ DD; Postnov IuV
    Biull Eksp Biol Med; 1988 May; 105(5):585-6. PubMed ID: 2898265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
    Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
    Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
    Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
    Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients.
    Lidereau R; Escot C; Theillet C; Champeme MH; Brunet M; Gest J; Callahan R
    J Natl Cancer Inst; 1986 Sep; 77(3):697-701. PubMed ID: 3462411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
    Stenman G; Sahlin P; Mark J; Landys D
    Oncogene; 1991 Jul; 6(7):1105-8. PubMed ID: 1677749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.
    Krontiris TG; DiMartino NA; Colb M; Parkinson DR
    Nature; 1985 Jan 31-Feb 6; 313(6001):369-74. PubMed ID: 2578622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas.
    Meyers SL; Dudley JP
    Mol Carcinog; 1992; 6(4):243-51. PubMed ID: 1362493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast, and ovarian cancer.
    Corell B; Zoll B
    Hum Genet; 1988 Jul; 79(3):255-9. PubMed ID: 2841224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the FGR protooncogene on the genetic linkage map of human chromosome 1p.
    Dracopoli NC; Stanger BZ; Lager M; Housman DE
    Genomics; 1988 Aug; 3(2):124-8. PubMed ID: 2906322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic DNA variability in human breast carcinoma.
    Olszewska E; Hay DE; Jones KW; Chetty U
    Oncogene; 1987; 1(4):403-8. PubMed ID: 2898746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.